Neuroscience
Neurotransmitter receptors function via various G-protein coupled and G-protein independent mechanisms that activate downstream intracellular signaling pathways such as cAMP/PKA, PI3K/AKT, phospholipase A2, and phospholipase C pathways. For instance, dopamine receptors act through adenylate cyclase to activate PKA and other signaling molecules, thereby mediate gene expression through the actions of CREB and other transcription factors. Other neurotransmitters such as NMDAR or AMPAR are associated with ion channels that control flux of Ca2+ and Na+, thus propagating the action potential across the post-synaptic neuron.
Dysfunctions in GABAergic/glutamatergic/serotonergic/dopaminergic pathways result in a broad range of neurological disorders such as chronic pain, neurodegenerative diseases, and insomnia, as well as mental disorders including schizophrenia, bipolar disorder, depression, and addiction.
- B6298 Bromocriptine mesylateSummary: A potent, selective D2-like dopamine receptor agonist
- B6317 4-DAMPSummary: A M3 cholinergic receptor antagonist
- B6328 Dimaprit dihydrochlorideSummary: H2 agonist
- B6363 5-MethylfurmethiodideSummary: muscarinic agonist
- B6380 Physostigmine hemisulfateSummary: cholinesterase inhibitor
- B6393 (±)-Vesamicol hydrochlorideSummary: acetylcholine transport inhibitor
- B6396 Mepyramine maleateSummary: inverse agonist for the H1 receptor
- B6398 trans-Triprolidine hydrochlorideSummary: H1 receptor antagonist
- B6406 (±)-EpibatidineSummary: nicotinic agonist
- B6417 AminopotentidineSummary: H2 antagonist